Cardiovascular disease models: A game changing paradigm in drug discovery and screening.

ABSTRACT: Cardiovascular disease is the leading cause of death worldwide. Although investment in drug discovery and development has been sky-rocketing, the number of approved drugs has been declining. Cardiovascular toxicity due to therapeutic drug use claims the highest incidence and severity of adverse drug reactions in late-stage clinical development. Therefore, to address this issue, new, additional, replacement and combinatorial approaches are needed to fill the gap in effective drug discovery and screening. The motivation for developing accurate, predictive models is twofold: first, to study and discover new treatments for cardiac pathologies which are leading in worldwide morbidity and mortality rates; and second, to screen for adverse drug reactions on the heart, a primary risk in drug devel

SUBMITTER: Savoji H 

PROVIDER: S-EPMC6397087 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature